DBVT Q4 2021 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+341.9% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$13M-459.7% margin

Net Income

-$14M-466.3% margin

EPS (Diluted)

$-1.25

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$147M

Total Liabilities

$47M

Stockholders' Equity

$99M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	-$1M	+341.9%
Gross Profit	$3M	-$1M	+341.9%
Operating Income	-$13M	-$40M	+66.4%
Net Income	-$14M	-$39M	+65.4%